BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
49.08
-1.15 (-2.29%)
At close: Aug 22, 2025, 4:00 PM
49.60
+0.52 (1.06%)
After-hours: Aug 22, 2025, 7:32 PM EDT

BridgeBio Pharma Revenue

BridgeBio Pharma had revenue of $110.57M in the quarter ending June 30, 2025, with 4,999.86% growth. This brings the company's revenue in the last twelve months to $235.81M, up 7.62% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.

Revenue (ttm)
$235.81M
Revenue Growth
+7.62%
P/S Ratio
39.48
Revenue / Employee
$323,030
Employees
730
Market Cap
9.38B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.